Antiemetic Use During Pregnancy

    Basic Details
    Date Posted
    Sunday, June 23, 2019
    Status
    Complete
    Medical Product
    doxylamine
    granisetron
    metoclopramide HCL
    netupitant/palonosetron HCl
    ondansetron
    palonosetron
    prochlorperazine
    promethazine HCl
    succinate/pyridoxine HCl
    Health Outcome(s)
    exposure in pregnancy
    Description

    This report contains the prevalence of antiemetic use among women of reproductive age who delivered a liveborn infant in the Mini-Sentinel Distributed Database (MSDD). Results for antiemetic use are also presented for a matched comparator cohort with no live-birth deliveries during the request period.

    Data from January 1, 2001 to December 31, 2014 from 15 Data Partners contributing to the MSDD were included in this report. This request was distributed to Data Partners on November 10, 2015.

    Additional Details
    FDA Center
    CDER
    Time Period
    January 1, 2001 to December 31, 2014
    Study Type
    Modular Program
    Assessment Type
    Exploratory Analyses
    Population / Cohort
    Females 54 years of age and younger
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)